Overview
CDNA market data
Price History
CDNA price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for CDNA. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Why Is CareDx Stock Skyrocketing Thursday?Benzinga · Jul 16, 2026, 6:08 PM
BTIG Maintains Buy on CareDx, Raises Price Target to $45Benzinga · Jul 16, 2026, 5:16 PM
Abbott Laboratories, AtaiBeckley, ManpowerGroup And Other Big Stocks Moving Higher On ThursdayBenzinga · Jul 16, 2026, 2:11 PM
CareDx shares are trading higher after the company announced the finalization of the Medicare Local Coverage Determination process related to molecular testing for solid organ allograft rejection.Benzinga · Jul 16, 2026, 12:54 PM
CareDx Finalizes Medicare Local Coverage Determination Procedure Regarding Molecular Testing For Solid Organ Allograft RejectionBenzinga · Jul 16, 2026, 12:35 PM
8-K filing — CareDx, Inc. (CDNA)SEC EDGAR · Jul 7, 2026, 9:12 PM
CareDx Completes Sale Of Its Lab Products Operations To Eurobio Scientific For $171.2MBenzinga · Jun 30, 2026, 8:15 PM
CareDx Announces Publication Of New Analysis Published In The Journal Of The American Society Of Nephrology Linking AlloSure Biomarkers With Trajectory Changes In Donor-Derived Cell-Free DNA TransplantsBenzinga · Jun 16, 2026, 8:15 PM